Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia

PURPOSE: Salvage options for patients who relapse after allogeneic stem-cell transplantation (allo-SCT) for acute myeloid leukemia (AML) and myelodysplasia (MDS) remain limited, and novel treatment strategies are required. Both lenalidomide (LEN) and azacitidine (AZA) possess significant antitumor a...

Descripción completa

Detalles Bibliográficos
Autores principales: Craddock, Charles, Slade, Daniel, De Santo, Carmela, Wheat, Rachel, Ferguson, Paul, Hodgkinson, Andrea, Brock, Kristian, Cavenagh, Jamie, Ingram, Wendy, Dennis, Mike, Malladi, Ram, Siddique, Shamyla, Mussai, Francis, Yap, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494237/
https://www.ncbi.nlm.nih.gov/pubmed/30653424
http://dx.doi.org/10.1200/JCO.18.00889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494237/
https://www.ncbi.nlm.nih.gov/pubmed/30653424
http://dx.doi.org/10.1200/JCO.18.00889

Ejemplares similares